Weight-dependent and weight-independent effects of dulaglutide on blood pressure in patients with type 2 diabetes

BACKGROUND: Patients with type 2 diabetes (T2D) treated with glucagon-like peptide-1 receptor agonists may experience reductions in weight and blood pressure. The primary objective of the current study was to determine the weight-dependent and weight-independent effects of ~ 6 months treatment with...

Descripción completa

Detalles Bibliográficos
Autores principales: Ferdinand, Keith C., Dunn, Julia, Nicolay, Claudia, Sam, Flora, Blue, Emily K., Wang, Hui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9999488/
https://www.ncbi.nlm.nih.gov/pubmed/36894938
http://dx.doi.org/10.1186/s12933-023-01775-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9999488/
https://www.ncbi.nlm.nih.gov/pubmed/36894938
http://dx.doi.org/10.1186/s12933-023-01775-x

Ejemplares similares